These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35480612)
1. Factors associated with medication adherence among people living with COPD: Pharmacists' perspectives. Bhattarai B; Walpola R; Khan S; Mey A Explor Res Clin Soc Pharm; 2021 Sep; 3():100049. PubMed ID: 35480612 [TBL] [Abstract][Full Text] [Related]
2. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study. Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacists' perspective of medication adherence support in Ethiopian hospital settings: a qualitative study. Tegegn HG; Wark S; Tursan d'Espaignet E; Spark MJ Int J Pharm Pract; 2023 Dec; 31(6):617-624. PubMed ID: 37721550 [TBL] [Abstract][Full Text] [Related]
4. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design. Buss VH; Shield A; Kosari S; Peterson GM; Naunton M Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556 [TBL] [Abstract][Full Text] [Related]
5. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study. Marquis J; Schneider MP; Spencer B; Bugnon O; Du Pasquier S Int J Clin Pharm; 2014 Oct; 36(5):1014-22. PubMed ID: 25139136 [TBL] [Abstract][Full Text] [Related]
6. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation. Fathima M; Saini B; Foster JM; Armour CL Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254 [TBL] [Abstract][Full Text] [Related]
7. Pharmacists' views on Indigenous health: is there more that can be done? Stoneman J; Taylor SJ Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377 [TBL] [Abstract][Full Text] [Related]
8. Concordance-based adherence support service delivery: consumer perspectives. Du Pasquier S; Aslani P Pharm World Sci; 2008 Dec; 30(6):846-53. PubMed ID: 18592393 [TBL] [Abstract][Full Text] [Related]
9. Enhancing community pharmacists' provision of medication adherence support to older adults: A mixed methods study using the Theoretical Domains Framework. Patton DE; Ryan C; Hughes CM Res Social Adm Pharm; 2021 Feb; 17(2):406-418. PubMed ID: 32217058 [TBL] [Abstract][Full Text] [Related]
10. Impact of community pharmacists in COPD management: Inhalation technique and medication adherence. Hesso I; Gebara SN; Kayyali R Respir Med; 2016 Sep; 118():22-30. PubMed ID: 27578467 [TBL] [Abstract][Full Text] [Related]
11. Pharmacists' strategies for promoting medication adherence among patients with HIV. Kibicho J; Owczarzak J J Am Pharm Assoc (2003); 2011; 51(6):746-55. PubMed ID: 22068197 [TBL] [Abstract][Full Text] [Related]
12. Hospital pharmacists' ethical exposure and decision-making. So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299 [TBL] [Abstract][Full Text] [Related]
13. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions. Katoue MG J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812 [TBL] [Abstract][Full Text] [Related]
14. Pharmacists' perceptions and communication of risk for alertness impairing medications. Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967 [TBL] [Abstract][Full Text] [Related]
15. Does hospitalization influence patients' medication adherence and community pharmacists' interventions? Beloin-Jubinville B; Joly-Mischlich T; Rouleau ED; Noiseux P; Blais L; Forget A; Beauchesne MF Ann Pharmacother; 2013 Sep; 47(9):1143-52. PubMed ID: 24259729 [TBL] [Abstract][Full Text] [Related]
16. Hospital pharmacists' and patients' views about what constitutes effective communication between pharmacists and patients. Chevalier BAM; Watson BM; Barras MA; Cottrell WN Int J Pharm Pract; 2018 Oct; 26(5):450-457. PubMed ID: 29210472 [TBL] [Abstract][Full Text] [Related]
17. Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists. Davis SR; Durvasula S; Merhi D; Young PM; Traini D; Bosnic Anticevich SZ Int J Clin Pharm; 2016 Feb; 38(1):135-43. PubMed ID: 26560115 [TBL] [Abstract][Full Text] [Related]
18. Hospital pharmacists' perceptions of medication counseling: A focus group study. Chevalier BA; Watson BM; Barras MA; Cottrell WN Res Social Adm Pharm; 2016; 12(5):756-71. PubMed ID: 26626591 [TBL] [Abstract][Full Text] [Related]
19. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives. Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151 [TBL] [Abstract][Full Text] [Related]
20. Barriers and Strategies for Improving Medication Adherence Among People Living With COPD: A Systematic Review. Bhattarai B; Walpola R; Mey A; Anoopkumar-Dukie S; Khan S Respir Care; 2020 Nov; 65(11):1738-1750. PubMed ID: 32576706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]